Editors' picksOPEN-SOURCE SCRIPT
Financial Growth
Updated
This indicator will acquire the financial data provided by Tradview.
the data is compare between Quarter, Annual and TTM in term of percent of growth.
YoY, QoQ and CAGR is also available by this script (The minimum is 4).
in addition, ploting of data, label and table also available (you can check the mark to toggle on / off).
Data : Revenue, Net Income, EBITDA, EPS, DVPS, Free Cash Flow and Forward PE .
How to use it.
just select the financial data, period and size of data to compare.
you can check the box to toggle the plotting line, label and table.
Enjoy.
the data is compare between Quarter, Annual and TTM in term of percent of growth.
YoY, QoQ and CAGR is also available by this script (The minimum is 4).
in addition, ploting of data, label and table also available (you can check the mark to toggle on / off).
Data : Revenue, Net Income, EBITDA, EPS, DVPS, Free Cash Flow and Forward PE .
How to use it.
just select the financial data, period and size of data to compare.
you can check the box to toggle the plotting line, label and table.
Enjoy.
Release Notes
Fix comparison calculations Release Notes
- More items added. - fixed CAGR.
New Items Added
- Key Financial Number : Revenue, Net Income, EBITDA, EPS, DVPS, Free Cash Flow, Total Debt
- Key Financial Ratio : Gross Margin, EBITDA Margin, Net Margin, ROE, ROA, Price to Book Value (P/BV), Price to Earnings (P/E)
Release Notes
Update Detail : 2022-Dec-17- Add 2 financial items.
- Add eps, diluted.
- Re-arrange code.
Release Notes
Re-arranged code. Add more items related to debt.
Release Notes
there's some problem about version.so i updated again.
Open-source script
In true TradingView spirit, the author of this script has published it open-source, so traders can understand and verify it. Cheers to the author! You may use it for free, but reuse of this code in publication is governed by House rules. You can favorite it to use it on a chart.
Want to use this script on a chart?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.